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Summary. Pulmonary emphysema refers to a lung 
disorder characterized by a diffuse destruction of the 
alveolar walls resulting in enlargement of the distal 
airspaces. The disease is usually a chronic, progressive, 
and disabling disorder. The concept of proteinaselanti- 
proteinase imbalance evolved from the identification of 
patients with al-antytripsin deficiency, and from the 
development of experimental emphysematous lesions 
using different enzymes. For a long time, this concept 
was seen as an elastase/antielastase imbalance, with the 
consequent degradation of elastin. Recent evidence, 
however, suggests that an intricate process of pulmonary 
remodeling occurs during the development of emphy- 
sema, where a complex network of serine proteases and 
metalloproteinases capable  of degrading different 
extracellular matrix molecules,  primarily, but not 
exclusively fibrillar collagens and elastin, are implicated 
in the pathogenesis of this disease. 
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oxidant burden on the lungs, producing 1017 oxidant 
molecules per puff (Church and Pryor, 1985). 
Emphysema is usually a progressive, and often 
disabling disease characterized by the abnormal and 
permanent enlargement of respiratory regions of the lung 
distal to the terminal bronchioles, accompanied by the 
destruction of the alveolar walls (Snider et al., 1985). 
According to their locations in the secondary pulmonary 
lobule, two major forms of emphysema have been 
described: panlobular and centrilobular. The most 
common form is represented by the centrilobular 
emphysema which is strongly associated with cigarette 
smoking, and results from destruction of alveoli around 
the proximal respiratory bronchiole.  This  form of 
emphysema shows predilection for the upper part of the 
individual lobes. In advanced stages of the disease, the 
emphysematous spaces may coalesce into large bullae 
which may reach several centimeters in diameter. On the 
other hand, panlobular emphysema exhibits a usual 
lower-lobe distribution and it is generally observed in 
patients with severe al-antiprotease deficiency; this 
form of the emphysema is characterized by the air space 
enlargement throughout the acinus. 
Introduction 
Pathogenic mechanisms of pulmonary emphysema 
Chronic obstructive pulmonary disease (COPD) is a 
prominent cause of morbidity and mortality among the 
adult population (Celli et al., 1995). The  disease is 
character ized by f ixed and i r revers ible  a i r - f low 
limitation in the lungs, and by emphysema, which 
ultimately provokes the loss of alveolar surface area for 
gas interchange, thus being responsible for most of the 
features of chronic and irreversible respiratory failure. 
Tobacco smoke is the most frequent identifiable risk 
factor for COPD. Cigarette smoke  consis ts  of an 
extremely complex mixture of compounds released into 
the respiratory tract, including highly reactive oxygen 
species. Actually, cigarette smoke imposes a huge 
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The proteinase/antiproteinase imbalance hypothesis 
This hypothesis, a s  a key concept in the patho- 
genesis of emphysema, arose from two indcpendent 
reports in the early 1960s. Firstly, Laurell and Eriksson 
(1963) identified a number of subjects with deficiency of 
al-antitrypsin, several of whom had also severe emphy- 
sema of early onset. al-antitrypsin - more appropriately 
al-antiprotease - is a major serine proteinase inhibitor, 
that is the principal inhibitor of neutrophil elastase. 
Although the liver appears to be the primary source of 
al-antiprotease inhibitor, recent evidence suggests that 
lung-derived epithelia1 cells, both bronchial and alveolar, 
are able to synthesize a fully active form of this inhibitor 
(Cichy et al., 1997). 
Forthwith, after Laurell and Eriksson's disclosure, 
imbalance in emphysema 
Gross et al. (1964) demonstrated that the use of a 
proteolytic enzyme (papain) was capable of inducing 
experimental lung lesions histologically similar to the 
human emphysema. These two pieces of evidence, 
suggested that emphysema could result as a direct 
consequence of an excessive proteinase burden in the 
lung milieu. 
Although al-antiprotease (al-AP) deficiency is the 
major studied form of genetic susceptibility associated to 
the development of emphysema, other genetic poly- 
morphism may also play a role. Recently, for example, 
an association between polymorphism in the gene for 
microsomal epoxide hydrolase (mEPHX) - an enzyme 
involved in the metabolism of highly reactive epoxide 
intermediates - and susceptibility to human emphysema 
was reported (Smith and Harrison, 1997). In that study, 
the proportion of individuals with innate slow mEPHX 
activity (homozygotes) was significantly higher in 
patients with COPD and emphysema, suggesting that 
genetic polymorphism involving xenobiotic enzymes 
may have a role in the susceptibility to oxidant-related 
lung disease. This is an important issue because an 
imbalance between oxidants and antioxidants has also 
been considered relevant in the pathogenesis of 
smoking-induced COPD and emphysema. The injurious 
effects of the increased oxidant burden in smokers 
include lipid peroxidation and oxidative protein damage, 
which, in turn, may alter the biological activity of 
receptors or antiproteinases enhancing the pathological 
response (Rahman and MacNee, 1996). 
Neutrophil elastase, the first piece of the proteinase/ 
antiproteinase puzzle 
A central role for neutrophil elastase was supported 
by several lines of evidence. In the 1970s it was shown 
that neutrophil elastase was also capable of provoking 
lung emphysema in experimental animals (Janoff et al., 
1977). Likewise, the enzyme was demonstrated in close 
association with interstitial elastic fibers in both 
emphysematous human lungs and in strains of mice 
spontaneously developing pulmonary emphysema 
(Damiano, 1986;  de Santi 1989). Therefore, the 
prevailing theory for almost 20 years was that diffuse 
emphysematous lesions developed as a result of an 
abnormal balance between neutrophil elastase and al- 
antiprotease in the lower respiratory tract (Janoff, 1985; 
Niewoehner, 1988).  This imbalance would be 
responsible for an excessive degradation of elastin, 
resulting in loss of the elastic properties of the lung. 
Elastin is  an important lung extracellular matrix 
molecule, composed of highly cross-linked, hydrophobic 
tropoelastin monomers, which provides resilience to 
elastic fibers,  allowing the characteristic lung 
mechanical behavior. 
According to this "elastase/antielastase imbalance" 
hypothesis,  cigarette compounds provoke the 
recruitment of neutrophils to the smoker's lungs, with 
the subsequent release of elastase into the lung 
connective tissue in concentrations that awfully surpass 
the ability of the proteinase inhibitor systems to 
inactivate them, thus resulting in destruction of elastic 
fibers, and in the development of emphysema. Besides, 
since tobacco smoke carries an enormous amount of free 
radicals, it may induce the inactivation of the a l -  
proteinase inhibitor,  through the oxidation of a 
methionine located in the active site of the inhibitor. 
Actually, in vivo studies supported the notion that the 
a l - A P  present in lung lavage from cigarette smokers 
exhibits reduced inhibitory capacity, which appeared to 
be related to the oxidation of the methionine residue 
(Gadek et al., 1979; Carp et al., 1982). Furthermore, 
alveolar inflammatory cells from smokers with 
emphysema also have the ability to inactivate a l - A P  
spontaneously whereas cells from smokers without 
detectable emphysema do not (Wallaert et al., 1993). 
Neutrophils versus macrophages in the pathogenesis of 
emphysema. Which is the culprit cell? 
Additional support for a deleterious role of neutro- 
phils, is the evidence suggesting that cigarette smoking 
provokes an increased lung neutrophil traffic in human 
and experimental animals (MacNee et al., 1989; Bosken 
et al., 1991). Cigarette smoke may increase neutrophil 
chemotaxis and sequestration in the lung micro- 
circulation, through an upregulation of interleukin-8 and 
neutrophil adhesion molecules (di Stefano et al., 1994; 
McCrea et al., 1994; Kanazawa et al., 1996). Interesting- 
ly, in the human disease, a weak but significant 
relationship between neutrophil sequestration and 
microscopic emphysema (alveolar wall per unit lung 
volume) has been found (Selby et al., 1994). Sequestered 
neutrophils may release a number of injurious products, 
including elastase and reactive oxygen species. 
However, most of the experimental evidence 
supporting a role for neutrophils grew largely from 
circumstantial evidence and is actually inconclusive. 
Thus, for example, the search for neutrophil elastase in 
the human disease has given controversial results, 
(Damiano et al., 1986; Fox et al., 1988), and some 
studies do not support the existence of high levels of 
elastase in association with elastin. Furthermore, a more 
severe elastase-induced emphysema was revealed in 
animals made neutropenic than in control animals with 
normal levels of neutrophils (Kuhn et al., 1980). 
Additionally, macrophages and not neutrophils, are the 
most abundant inflammatory cells found in bronchio- 
alveolar lavage (BAL) of cigarette smokers, as well as in 
respiratory bronchioles where emphysematous changes 
are first apparent (Niewoehner et al., 1974; Merchant et 
al., 1992). In this context, it has been recently shown that 
the extent of alveolar septa destruction in human 
emphysematous lungs, is associated to the number of 
alveolar macrophages and l'-lymphocytes present in the 
areas of lung destruction (Finkelstein et al., 1995). 
Interestingly enough, a negative correlation was found 
between the number of neutrophils and the emphy- 
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sematous lesions. Taken together, morphometric and 
BAL cell profile strongly suggest that macrophages are 
the most abundant inflammatory cells in the areas where 
lung is being destroyed, and that they are in close 
relationship to the alveolar disruption. Of course, 
nobody can negate a role for neutrophils, mainly 
immediately after smoking, and during lung infections; a 
frequent complication in COPD patients which worsens 
the natural history of the disease. 
Both alveolar macrophages and neutrophils not only 
produce a number of enzymes, but are also a potential 
source of oxidants in the lower respiratory tract of 
cigarette smokers. As mentioned before, these oxidants 
can in turn inactivate al-AP, rendering it ineffective as 
an inhibitor of neutrophil elastase (Hubbard et al., 1987). 
On the other hand, the contribution of other cells in 
the development of emphysema warrants further studies, 
and particularly, the participation of fibroblasts is a long 
way from being elucidated. There is some evidence 
suggesting that cigarette smoke extract inhibits fibroblast 
proliferation and migration, at least in vitro (Nakamura 
et al., 1995). If tobacco induces dysfunction of 
pulmonary fibroblasts it may affect quantitatively and 
qualitatively the production of extracellular matrix 
proteins altering the dynamics of tissue repair after the 
destructive events. In other words, emphysema could 
also be seen as a deficiency in tissue repair after alveolar 
disruption. Since fibroblasts are the main local cells 
responsible for the synthesis of the structural 
components of the alveolar walls including collagens, 
elastin, fibronectin, and proteoglycans, putative 
fibroblast alterations provoked by tobacco smoke 
might also participate in the pathological response. 
Additionally, fibroblasts are an important source of a 
variety of matrix metalloproteinases (MMP), tissue 
inhibitors of metalloproteinases (TIMP), and a 2  
macroglobulin (Raghu and Kavanagh, 1991; Pardo et al., 
1992); all of them playing a central role in matrix 
remodeling. 
On the other hand, fibroblasts participate in the 
pathological changes of the COPD airways. It is well 
known, for example, that fibrosis as well as peri- 
bronchial inflammation are key lesions in chronic 
bronchitis and in the permanent narrowing of the small 
airways, the partners of emphysema in COPD (Chanez 
et al., 1997). 
Metalloproteinasases, the missing pieces of the 
proteinase/antiproteinase puzzle 
The metalloproteinases are a family of secreted or 
transmembrane proteins that are capable of degrading 
virtually all extracellular matrix and basement 
membrane components. The MMP family consists of at 
least four different subclasses of zinc- and calcium- 
dependent endopeptidases that are synthesized as 
proenzymes and become activated through proteolytic 
cleavage. Based on their substrate affinity and structural 
domains, MMPs have been classified into collagenases, 
gelatinases, stromelysins, and membrane-type metallo- 
proteinases (Matrisian, 1992; Woessner, 1994). The 
collagenase subfamily includes interstitial collagenase 
(MMP-l ) ,  neutrophil collagenase (MMP-g), and 
collagenase 3 (MMP-13), which have substrate 
specificity for fibrillar collagens (Goldberg et al., 1986; 
Hasty et al., 1990; Freije et al., 1994). The gelatinase 
subfamily is composed of two members, Gelatinase A 
(MMP-2) and Gelatinase B (MMP-9). Their substrate 
specificity involves the degradation of type IV collagen, 
the major structural component of basement membranes, 
denatured collagens (gelatin), as well as insoluble elastin 
(Collier et al., 1988; Wilhem et al., 1989; Senior et al., 
1991). The stromelysin subgroup comprises, strome- 
lysins 1 and 2, (MMP-3 and MMP-10) two highly 
homologous enzymes, and stromelysin 3 (MMP-11) 
which share substrate specificity with matrilysin (MMP- 
7) for proteoglycans, fibronectin, laminin, and the 
globular domain of type IV collagen (Basset et al., 1990; 
Birkedal-Hansen et al., 1993). Metalloelastase (MMP- 
12) with elastin degrading ability has also been classified 
in this subgroup (Shapiro et al., 1993). New members of 
the MMP family have been recently cloned (MMP-18 
and MMP-19) although their substrate affinity has not 
yet been determined (Cossins et al., 1996; Pendas et al., 
1997). Finally, the membrane-type metalloproteinases 
(MT-MMP) include four different enzymes (Sato et al., 
1994; Takino et al., 1995; Will et al., 1995; Puente et al., 
1996). Their physiological roles are not precisely 
defined yet, but they have been involved in cell surface 
activation of progelatinase A. Interestingly, MTl-MMP 
has been shown to digest interstitial collagens (Ohuchi et 
al., 1997). 
Macrophages are a major source of metallo- 
proteinases capable of lung destruction, including 
interstitial collagenase-l and collagenase-3 (MMP-1, 
MMP-13) (Pardo et al., 1996; Selman et al., 1996), and 
at least four different enzymes which are also able to 
degrade insoluble elastin: metalloelastase (MMP-12), 
matrilysin (MMP-7), and gelatinases A and B (MMP-2, 
MMP-9) (Shapiro, 1994; Busiek et al., 1995; Shipley et 
al., 1996). 
Evidence supporting a role for metalloelastase was 
recently found in mice made genetically deficient in 
MMP-12 by gene targeting (Hautamaki et al., 1997). 
Whereas wild-type mice revealed an increased 
inflammatory cell recruitment and emphysematous 
lesions when they were chronically exposed to cigarette 
smoke, macrophage elastase-deficient mice did not 
present increased numbers of lung macrophages and did 
not develop emphysema. 
Likewise, an upregulation of gelatinase B, has been 
described in human and experimentally-induced 
emphysema (Rosenbluth et al., 1995; Segura et al., 1995; 
Horiba et al., 1997). Cells expressing gelatinase B are 
located along alveolar walls and in the alveolar spaces 
and interstitium, and most likely represent activated 
alveolar and interstitial macrophages, neutrophils and 
probably some epithelia] cells. Therefore, at least two 
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metalloproteinases with elastin substrate specificity 
seem to be involved in emphysematous lung destruction. 
A putative role for interstitial collagenase 
The interstitial compartment of the alveolar walls is 
the space between the alveolar and capillary basal 
laminae. Fibrillar collagens and elastin are the major 
extracellular matrix components of this compartment 
and play a vital physiological role in ventilation, 
enabling the tissue to stretch during inflation, preventing 
over-inflation and facili tating subsequent recoil .  
Actually, collagens are the most abundant proteins in the 
lung parenchyma and to date, four molecular types of 
collagen (I ,  111, V, and VI) have been found in the 
interstitium, whereas type IV collagen is an important 
component of the basement membranes (Turino, 1985; 
Specks et al., 1995). In addition, a number of other 
macromolecules, such as proteoglycans and fibronectin 
are also part of this dynamic and complex structure. 
During the development of emphysema, the alveolar 
walls are completely destroyed and in more advanced 
stages, the emphysematous spaces may coalesce into 
larger bullae where gas interchange is non-existent. In 
this context. breakdown of interstitial fibrillar colla~ens 
'2 
appears to  be a fundamental step in the micro-  
environmental disruption of alveolar walls. Moreover, 
the disappearance of huge numbers of delicate alveolar- 
capillary structures should involve the multiple action of 
different extracellular-matrix proteolytic enzymes 
released into the local milieu. 
The  first  important contribution support ing a 
putative role for interstitial collagenase in the patho- 
genesis of pulmonary emphysema was reported by 
D'Armiento et al .  (1992) who demonstrated that 
transgenic mice overexpressing MMP-1 in their lungs 
developed morphological  changes consis t ing in 
disruption of alveolar walls and coalescence of the 
alveolar spaces remarkably similar to human emphy- 
sema. Interestingly, no evidence of inflammation or 
fibrosis was observed, and furthermore a decrease of 
collagen fibers was noticed whereas elastin appeared to 
be normal. The association of collagenase transgene and 
emphysematous lesions were further confirmed since 
there was a positive relationship between the levels of 
col lagenase expression and the severity of the 
emphysematous lesions. 
Subsequently, similar findings were found in our 
laboratory using an experimental model induced by 
tobacco smoke in guinea pigs (Selman et al., 1996). 
During cigarette smoke exposure lungs developed first a 
multifocal inflammation in the lower respiratory tract, 
and, after several weeks, a varied degree of emphy- 
sematous lesions. These pathological changes coincided 
with a marked increase in interstitial collagenase 
expression and activity. The increase of collagenase 
activity was progressive and occurred in the presence of 
a higher degree of inflammation and alveolar walls 
rupture, suggesting that active collagen breakdown is 
taking place during the development of emphysema. 
Some recent reports have suggested that an up- 
regulation of interstitial collagenase also occurs in 
human emphysematous lung tissues. Finlay et al. 
(1997a), showed that alveolar macrophages obtained 
from patients with pulmonary emphysema have elevated 
mRNA transcripts for interstitial collagenase and 
gelatinase B when compared with normal volunteers. 
Moreover, unlike the other MMPs examined (gelatinases 
A and B, and metalloelastase) where expression was 
detectable in all study samples, mRNA transcripts for 
MMP-l were distinguishable only in 20% of control 
samples compared with 100% of emphysematous 
patients. Intriguingly, transcript levels of metalloelastase 
were as in control samples, placing in some stress 
previous findings in transgenic mice (Hautamaki et al., 
1997). Collagenase activity has been also found elevated 
in BAL fluid from patients with emphysema and seems 
to be a better indicator for the presence of the disease 
than elastase (Finlay et al., 1997b). 
Nevertheless, a complex and probably compart- 
mentalized inflammatorylrepair,  proteinaselanti- 
proteinase process seems to take place in the lungs since, 
although measurements  of collagen have given 
contradictory results, two recent studies have suggested 
that areas of alveolar wall fibrosis with net increase in 
interstitial collagen are present in human pulmonary 
emphysema (Cardoso et al., 1993; Lang et al., 1994). 
Similarly, a pattern of thickened fibrils and disorganized 
deposition of collagen was observed in emphysematous 
human lungs, and in elastase-induced experimental 
emphysema (Finlay et al., 1996). In long-term smoke- 
induced emphysema in guinea pigs, morphometric and 
ultrastructural evidence of collagen breakdown and 
resynthesis have also been found (Wright and Churg, 
1995).  In general terms, these findings might be 
interpreted as  representing a disturbance in both 
pathways of collagen homeostasis with an excessive 
collagen degradation participating in alveolar wall 
destruction, whereas an increased collagen synthesis 
may produce discrete foci of interstitial fibrosis.  
Intriguingly enough, although pulmonary emphysema 
and diffuse lung f ibrosis  have been classically 
considered to represent two separate disorders, some 
studies have revealed an occasional association between 
both disorders (Hiwatari et al., 1993). 
A vicious circle between enzymes and inhibitors may 
autoperpetuate alveolar disruption 
Excessive activity of interstitial collagenases may 
more extensively affect the lung connective tissue 
metabolism because both, macrophagelfibroblast 
collagenase and neutrophil collagenase, are able to 
hydrolyze and inactivate a l -p ro t e ina se  inhibitor 
(Michaelis et al., 1990; Desrochers et al., 1991). The 
obvious consequence i s  that collagenases may 
participate in this pathological process not only through 
the abnormal remodeling of the lung fibrillar collagens, 
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but also by enhancing an imbalance in the serine- 
proteinaselal-proteinase inhibitor thus contributing to 
increased elastolytic activity. Similarly, other metallo- 
proteinases, such as stromelysins 1 and 3 are also able to 
inactivate al-antiproteinase and consequently, they also 
may intensify the activity of neutrophil elastase 
(Winyard et al., 1991; Anderson et al., 1995). 
On the other face of these interrelated enzymatic 
activities, some serine proteases, such as neutrophil 
elastase, are capable of degrading tissue inhibitor of 
metalloproteinases, thus increasing collagenolytic and 
other metalloproteinases activities (Okada et al., 1988). 
In summary, a large and growing body of evidence 
strongly suggests that the emphysematous lesion 
involves more than neutrophil elastase and elastic tissue 
disruption, and that alternative proteolytic enzymes, i.e. 
interstitial collagenase, and gelatinase B, contribute to 
the lung disease. This complex network is further 
exemplified by findings showing the presence of 
structural changes or altered processing of heparan 
sulfate in patients with emphysema which may alter the 
stability of the alveolar extracellular matrix (Van de Lest 
et al., 1996). Actually, experimental inhibition of proteo- 
glycan synthesis results in considerable emphysematous 
lung destruction (Van Kuppevelt et al., 1997). 
Therefore, it is now impossible to conceive that a 
single proteinase, regardless of how all-powerful it may 
be, could be responsible for the destruction of alveolar 
walls. 
Treatment of COPD has primarily been supportive 
and has included among others, the use of exercise and 
rehabilitation, supplementary oxygen, bronchodilators, 
antibiotics etc., and it has also be directed at changes in 
lifestyle; particularly smoking cessation. Additionally, 
lung reduction surgery and lung transplantation are 
currently under research. In general,  however, 
management of COPD has been largely unsuccessful. In 
this context, new directions for effective therapy may 
arise from a better understanding of the complex 
mechanisms involved in the pathogenesis of this 
disorder. Since the lung is a readily accesible target 
organ for gene therapy, continuing improvements in 
DNA recombinant technologies will contribute to the 
development of new therapeutic strategies. 
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